ArticleMedical decision making : an international journal of the Society for Medical Decision Making2019
Personalized Decision Making for Biopsies in Prostate Cancer Active Surveillance Programs.
Article in Medical decision making : an international journal of the Society for Medical Decision Making, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 citations in OpenAlex.
- Optimizing personalized screening intervals for clinical biomarkers using extended joint models.Journal of applied statistics · 2026Article
- Projected outcomes of reduced-biopsy management of Grade Group 1 prostate cancer: implications for relabeling.Journal of the National Cancer Institute · 2025Article
- A Personalized, Risk-Based Approach to Active Surveillance for Prostate Cancer with Takeaways from Broader Oncology Practices: A Mixed Methods Review.Journal of personalized medicine · 2025Review
- Joint models for dynamic prediction in localised prostate cancer: a literature review.BMC medical research methodology · 2022Review
- Shared decision making of burdensome surveillance tests using personalized schedules and their burden and benefit.Statistics in medicine · 2022Article
- Active surveillance for prostate cancer-will the discoveries of the last 5 years change the future?Translational andrology and urology · 2021Article
- Personalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance.BJU international · 2021Article
- Cardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance:JACC. CardioOncology · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.